These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24630639)

  • 1. [The observatory of rare malignant gynecologic tumors].
    Devouassoux-Shisheboran M; Vacher-Lavenu MC;
    Ann Pathol; 2014 Feb; 34(1):70-3. PubMed ID: 24630639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathologists and the French network of expertise on rare cancers ENT: The REFCORpath].
    Badoual C; Baglin AC; Wassef M; Thariat J; Reyt E; Janot F; Baujat B;
    Ann Pathol; 2014 Feb; 34(1):64-9. PubMed ID: 24630638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer].
    Rousset-Jablonski C; Selle F; Adda-Herzog E; Planchamp F; Selleret L; Pomel C; Chabbert-Buffet N; Daraï E; Pautier P; Trémollières F; Guyon F; Rouzier R; Laurence V; Chopin N; Faure-Conter C; Bentivegna E; Vacher-Lavenu MC; Lhomme C; Floquet A; Treilleux I; Lecuru F; Gouy S; Kalbacher E; Genestie C; de la Motte Rouge T; Ferron G; Devouassoux-Shisheboran M; Kurtz JE; Namer M; Joly F; Pujade-Lauraine E; Grynberg M; Querleu D; Morice P; Gompel A; Ray-Coquard I
    Bull Cancer; 2018 Mar; 105(3):299-314. PubMed ID: 29397916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatments for rare ovarian tumors: What's new?].
    Lebreton C; Quesada S; Bini M; Babin G; Rossi L; Chopin N; Croce S; Hartog C; Renaud T; Gaillard AL; Petit A; Serre AA; Trédan O; Rowinski E; Cockenpot V; Treilleux I; Rousset-Jablonski C; Méeus P; Guyon F; Ray-Coquard I
    Bull Cancer; 2023; 110(7-8):818-824. PubMed ID: 37045734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential histological discordance revealed by second review in the national rare gynecological cancer network (TMRG).
    Henno S; Jeanne C; Rouge TM; Genestie C; Treilleux I; Croce S; Just PA; Le Frere-Belda MA; Guinaudeau E; Penault-Llorca F; Arnould L; Mery-Lamarche E; Leroux A; Lemaire AS; Averous G; Renaud O; Charafe-Jauffret E; Bonneau C; Leaha C; Ray-Coquard I; Devouassoux-Shisheboran M
    Gynecol Oncol; 2022 Jun; 165(3):637-641. PubMed ID: 35393217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [TENpath network, an expertise pathology network dedicated to sporadic and inherited adult neuroendocrine tumors: first evaluation and first lessons].
    Scoazec JY;
    Ann Pathol; 2014 Feb; 34(1):34-9. PubMed ID: 24630635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Networking for ovarian rare tumors: a significant breakthrough improving disease management.
    Chiannilkulchai N; Pautier P; Genestie C; Bats AS; Vacher-Lavenu MC; Devouassoux-Shisheboran M; Treilleux I; Floquet A; Croce S; Ferron G; Mery E; Pomel C; Penault-Llorca F; Lefeuvre-Plesse C; Henno S; Leblanc E; Lemaire AS; Averous G; Kurtz JE; Ray-Coquard I
    Ann Oncol; 2017 Jun; 28(6):1274-1279. PubMed ID: 28398524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The RENAPE network: towards a new healthcare organization for the treatment of rare tumors of the peritoneum. Description of the network and role of the pathologists].
    Villeneuve L; Isaac S; Glehen O; Capovilla M; Chevallier A; Croce S; Dartigues P; Fontaine J; Kaci R; Lang-Averous G; Laverriere MH; Leroux-Broussier A; Mery E; Poizat F; Valmary-Degano S; Verriele-Beurrier V; Gilly FN; Bibeau F
    Ann Pathol; 2014 Feb; 34(1):4-8. PubMed ID: 24630631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a second opinion using expression and molecular analysis of FOXL2 for sex cord-stromal tumors. A study of the GINECO group & the TMRO network.
    Maillet D; Goulvent T; Rimokh R; Vacher-Lavenu MC; Pautier P; Alexandre J; Pujade-Laurraine E; Devouassoux-Shisheboran M; Treilleux I; Ray-Coquard I; Savina A
    Gynecol Oncol; 2014 Jan; 132(1):181-7. PubMed ID: 24157616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Constitutive characteristics and change trend of gynecological malignant tumors in 8009 hospitalized patients in Guangxi Zhuang Autonomous Region].
    Huang W; Li L; Yu DQ; Huang YL; Liu Y; Chen XQ; Tang BJ; Xu H; Ma G; Dong LH; Li L; Qiu Y; Bai H; Nong WZ; Li L; Zeng DY; Jiang FY; Lan Y; Ye Y; Tang XZ; Wang DX; Li HZ; Pan YB; Mo AX; Wu XY; Lei ZY; Zhou GP; Liu C; Su QH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):22-5. PubMed ID: 17331416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of rare ovarian cancers: the experience of the French website "Observatory for rare malignant tumours of the ovaries" by the GINECO group: interim analysis of the first 100 patients.
    Ray-Coquard I; Weber B; Lotz JP; Tournigand C; Provencal J; Mayeur D; Treilleux I; Paraiso D; Duvillard P; Pujade-Lauraine E;
    Gynecol Oncol; 2010 Oct; 119(1):53-9. PubMed ID: 20580063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [National network of paediatric central nervous system tumours reviewing by the Groupe d'Étude de Neuropathologie Oncologique Pediatrique (GENOP)].
    Meyronet D; Silva K; Figarella-Branger D; Godfraind C; Delisle MB; Maurage CA; Miquel C; Varlet P; Gentet JC; Salamon AI; Vasiljevic A; Jouvet A
    Ann Pathol; 2014 Feb; 34(1):74-86. PubMed ID: 24630640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [RENAPE network: Towards more equitable access to care and expertise for patients with rare peritoneal cancers].
    Villeneuve L; Odin C; Bonnefoy I; Pichon P; Valmary-Degano S; Bibeau F; ;
    Ann Pathol; 2024 Jul; 44(4):291-295. PubMed ID: 38839525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rythmic-pathology: the French national pathology network for thymic epithelial tumours].
    Chalabreysse L; Thomas De Montpreville V; De Muret A; Hofman V; Lantuejoul S; Parrens M; Payan MJ; Rouquette I; Secq V; Girard N; Marx A; Besse B; Molina TJ
    Ann Pathol; 2014 Feb; 34(1):87-91. PubMed ID: 24630641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rare tumors of the head and neck; on behalf of the REFCOR, the French Network of rare head and neck tumors].
    Baujat B; Thariat J; Baglin AC; Costes V; Testelin S; Reyt E; Janot F;
    Bull Cancer; 2014 May; 101(5):411-23. PubMed ID: 24886891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine tumors of the gynecologic tract: select topics.
    Rouzbahman M; Clarke B
    Semin Diagn Pathol; 2013 Aug; 30(3):224-33. PubMed ID: 24144291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New clinical research strategies for rare gynecologic malignancies.
    Ray-Coquard I; Pujade-Lauraine E; Ledermann JA
    Curr Opin Obstet Gynecol; 2015 Feb; 27(1):53-7. PubMed ID: 25490380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follow-up of gynecological cancer patients after treatment - the views of European experts in gynecologic oncology.
    Vistad I; Cvancarova M; Salvesen HB
    Acta Obstet Gynecol Scand; 2012 Nov; 91(11):1286-92. PubMed ID: 22880840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Management and Prognostic Factors for Ovarian Malignant Tumours in Adolescents: A Comprehensive Review of Current Guidelines.
    Margioula-Siarkou C; Petousis S; Margioula-Siarkou G; Mavromatidis G; Chatzinikolaou F; Hatzipantelis E; Guyon F; Dinas K
    Diagnostics (Basel); 2023 Mar; 13(6):. PubMed ID: 36980387
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.